Education
About Us
Working with TipRanks
Follow Us
Vicarious Surgical (RBOT)
NYSE:RBOT
Earnings Data
Report Date
Aug 11, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
-2.5Last Year’s EPS
-2.86Same Quarter Last Year
Moderate Buy
Based on 3 Analysts Ratings
Earnings Call Summary
Earnings Call Date:May 12, 2025
|% Change Since: -10.71%
|Next Earnings Date:Aug 11, 2025
Earnings Call Sentiment|Neutral
The earnings call highlighted significant strategic partnerships and progress toward clinical milestones while acknowledging ongoing challenges with cash burn and regulatory processes. Despite some concerns, there is optimism about achieving major milestones in 2025.Company Guidance
During Vicarious Surgical's 2025 First Quarter Earnings Call, the company provided guidance on several key metrics and strategic initiatives. The call highlighted the company's transition towards becoming a clinical-stage entity, anticipating the treatment of initial patients later in 2025 with its single-port surgical system. The company outlined its strategic focus on inventory buildup and rigorous testing, including sterility and biocompatibility, to ensure readiness for clinical trials. Financially, Vicarious Surgical reported total operating expenses of $15.7 million for Q1 2025, a slight decrease from the previous year, with R&D expenses accounting for $9.4 million. The firm's GAAP net loss was $15.4 million, or $2.60 per share, compared to a net loss of $17 million, or $2.90 per share, in Q1 2024. The call also discussed the company's cash position of approximately $37 million and a projected full-year cash burn of $50 million, emphasizing disciplined capital allocation and strategic financing plans. The company celebrated a new strategic partnership with UMass Memorial Medical Center, aimed at refining surgical workflows and enhancing surgeon education, underscoring its commitment to successful commercialization of its V1.0 system.Strategic Hospital System Partnership
Vicarious Surgical announced a strategic partnership with UMass Memorial Medical Center to optimize robotic system implementation and enhance surgeon education.
Decrease in Operating Expenses
Total operating expenses decreased by 2% to $15.7 million in Q1 2025 compared to $16.1 million in Q1 2024.
Successful Development and Testing Progress
Completion of the first patient card and surgeon console for formal preclinical testing, and advancements in system integration and instrument production.
Optimism for 2025 Clinical Milestone
Anticipation of Vicarious Surgical evolving into a clinical-stage company in 2025 with the first clinical patients using the single-port surgical system.
RBOT Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
RBOT Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 12, 2025 | $8.87 | $7.90 | -10.94% |
Mar 17, 2025 | $9.63 | $8.20 | -14.85% |
Nov 12, 2024 | $11.14 | $9.15 | -17.86% |
Aug 12, 2024 | $5.50 | $5.21 | -5.27% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Vicarious Surgical (RBOT) report earnings?
Vicarious Surgical (RBOT) is schdueled to report earning on Aug 11, 2025, TBA Not Confirmed.
What is Vicarious Surgical (RBOT) earnings time?
Vicarious Surgical (RBOT) earnings time is at Aug 11, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is RBOT EPS forecast?
RBOT EPS forecast for the fiscal quarter 2025 (Q2) is -2.5.